[1] |
Jia Fan, Tian Lijuan.
Research on the Improvement of Incentive Mechanism for Pharmaceutical Sales Personnel - Taking Company A as an Example
[J]. Asian Journal of Social Pharmacy, 2024, 19(3): 272-278.
|
[2] |
Chang Yingnan, Gong Jingran, Chang Senhao, Chen Yuwen.
Strategic Planning for Drug Regulatory Science in the United States and Its Enlightenments to China
[J]. Asian Journal of Social Pharmacy, 2023, 18(2): 91-97.
|
[3] |
Li Wanying, Zhang Weiwei, Jia Siyao, Dong Li.
Influence and Suggestions on Trial Implementation Measures for Early Settlement Mechanism of Drug Patent Disputes
[J]. Asian Journal of Social Pharmacy, 2023, 18(2): 149-156.
|
[4] |
Cui Li, Xing Hua.
Enlightenment and Suggestions on the Construction of Information Platform and Processing Mechanism of Drug Shortages in Developed Countries to China
[J]. Asian Journal of Social Pharmacy, 2023, 18(2): 177-186.
|
[5] |
Wang Guanjie, Shao Mingli.
Research on the Development of Drug Regulatory Science in China
[J]. Asian Journal of Social Pharmacy, 2022, 17(4): 285-290.
|
[6] |
Liao Wenjing, Lin Xiangpeng, Liu Liang, Dou Lele, Wang Shuling.
Reflections on the Participation of Social Organizations in the Prevention of COVID-19
[J]. Asian Journal of Social Pharmacy, 2022, 17(4): 376-382.
|
[7] |
Wang Shuling, Dou Lele, Lin Xiangpeng, Liu Liang, Chen Hui.
Comparative Analysis of Social Forces Participating in Emergency Management of Public Health Events in China, Australia, Germany and the United States
[J]. Asian Journal of Social Pharmacy, 2022, 17(2): 144-158.
|
[8] |
Qiu Yu, Zhang Fang.
A Review of the Development and Effect of Contraceptive Counseling After Abortion
[J]. Asian Journal of Social Pharmacy, 2022, 17(1): 61-69.
|
[9] |
Yang Yu, Shi Yu, Hu Rongbo, Tian Lijuan.
Research and Enlightenment of EU Drug Risk Management Plan
[J]. Asian Journal of Social Pharmacy, 2021, 16(1): 23-30.
|
[10] |
Wang Zhonghua, Wu Zhi’ang.
Perfecting the Incentive Mechanism for Pharmaceutical University Staff
in China: Strategies and Suggestions
[J]. Asina Journal Of Social Pharmacy, 2018, 13(3): 75-79.
|
[11] |
Jin Quanyuan, Lin Xiaohui, Dong Li.
Research on Setting up Patent Risk Management System in Medical colleges and universities in China
[J]. Asina Journal Of Social Pharmacy, 2018, 13(1): 8-15.
|
[12] |
Yu Hongjian, Wu Chunfu.
Comprehensive Evaluation of Plant Polyphenols
Development Projects Based on FANP-SVM
[J]. Asina Journal Of Social Pharmacy, 2017, 12(1): 1-6.
|
[13] |
WANG Ming-dong;LI Ye;SHAO Da-li;ZHANG Lu.
Drug Advertising Regulations in China: A Current Status Study
[J]. , 2013, 8(1): 6-9.
|
[14] |
GUO Ying;TIAN Li-juan;HAN Xu.
Perfecting Drug Recall System in China: Suggestions and Methods
[J]. , 2012, 7(1): 40-44.
|
[15] |
XI Xiao-yu;CHEN Gao-jie;CHU Shu-zhen .
Coordination Mechanism for Implementing Essential Drug System
[J]. , 2011, 6(2): 73-78.
|